Document Detail


The use of olanzapine in the treatment of negative symptoms in Alzheimer's disease.
MedLine Citation:
PMID:  16179669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The authors report findings from an 8-week, open-label trial conducted to evaluate efficacy of olanzapine in treating negative symptoms in Alzheimer's disease (AD). Subjects were AD patients age 50 and older who exhibited untreated neuropsychiatric symptoms. Findings suggest that a therapeutic profile for olanzapine may be appropriate for AD patients experiencing neuropsychiatric problems.
Authors:
Eric D Rankin; Richard D Layne
Related Documents :
18957729 - Non-pharmacological and pharmacological treatment of the cognitive and behavioral sympt...
20003629 - Relationship of frontal lobe dysfunction and aberrant motor behaviors in patients with ...
11396869 - Switching previous therapies for alzheimer's disease to galantamine.
21475949 - Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary di...
1673209 - Tacrine in alzheimer's disease.
19371569 - A randomized controlled trial of homeopathic treatment of weaned piglets in a commercia...
22156719 - The structure of women's mood in the early postpartum.
18289149 - Six-month paroxetine treatment of premenstrual dysphoric disorder: continuous versus in...
23440839 - Multidisciplinary rehabilitation after primary brain tumour treatment.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of neuropsychiatry and clinical neurosciences     Volume:  17     ISSN:  0895-0172     ISO Abbreviation:  J Neuropsychiatry Clin Neurosci     Publication Date:  2005  
Date Detail:
Created Date:  2005-09-23     Completed Date:  2005-11-14     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8911344     Medline TA:  J Neuropsychiatry Clin Neurosci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  423-4     Citation Subset:  IM    
Affiliation:
Department of Behavioral Medicine and Psychiatry, West Virginia University, 930 Chestnut Ridge Rd., Morgantown, WV 26505-2854, USA. erankin@hsc.wvu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Alzheimer Disease / complications
Antipsychotic Agents / therapeutic use*
Behavioral Symptoms / drug therapy*,  etiology
Benzodiazepines / therapeutic use
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Neuropsychological Tests / statistics & numerical data
Schizophrenic Psychology*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aripiprazole in psychosis associated with Parkinson's disease.
Next Document:  Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and ...